Literature DB >> 30653845

Risk stratification of myocardial injury after liver transplantation in patients with computed tomographic coronary angiography-diagnosed coronary artery disease.

Young-Jin Moon1, Hye-Mee Kwon1, Kyeo-Woon Jung1, Hye-Won Jeong1, Yong-Seok Park1, In-Gu Jun1, Jun-Gol Song1, Gyu-Sam Hwang1.   

Abstract

We aimed to determine if the severity of computed tomographic coronary angiography (CTCA)-diagnosed coronary artery disease (CAD) is associated with postliver transplantation (LT) myocardial infarction (MI) within 30 days and early mortality. We retrospectively evaluated 2118 consecutive patients who underwent CAD screening using CTCA. Post-LT type-2 MI, elicited by oxygen supply-and-demand mismatch within a month after LT, was assessed according to the severity of CTCA-diagnosed CAD. Obstructive CAD (>50% narrowing, 9.2% prevalence) was identified in 21.7% of patients with 3 or more known CAD risk factors of the American Heart Association. Post-LT MI occurred in 60 (2.8%) of total patients in whom 90-day mortality rate was 16.7%. Rates of post-LT MI were 2.1%, 3.1%, 3.4%, 4.3%, and 21.4% for normal, nonobstructive CAD, and 1-, 2-, and 3-vessel obstructive CAD, respectively. Two-vessel or 3-vessel obstructive CAD showed a 4.9-fold higher post-LT MI risk compared to normal coronary vessels. The sensitivity and negative predictive value of obstructive CAD in detecting post-LT MI were, respectively, 20% and 97.5%. In conclusion, negative CTCA finding in suspected patients can successfully exclude post-LT MI, whereas proceeding with invasive angiography is needed to further risk-stratify in patients with significant CTCA-diagnosed CAD. Prognostic role of CTCA in predicting post-LT MI needs further research.
© 2019 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  clinical research/practice; coronary artery disease; diagnostic techniques and imaging: coronary angiography; heart failure/injury; liver transplantation/hepatology

Year:  2019        PMID: 30653845     DOI: 10.1111/ajt.15263

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  5 in total

Review 1.  Management of cardiac diseases in liver transplant recipients: Comprehensive review and multidisciplinary practice-based recommendations.

Authors:  Manhal Izzy; Brett E Fortune; Marina Serper; Nicole Bhave; Andrew deLemos; Juan F Gallegos-Orozco; Cesar Guerrero-Miranda; Shelley Hall; Matthew E Harinstein; Maria G Karas; Michael Kriss; Nicholas Lim; Maryse Palardy; Deirdre Sawinski; Emily Schonfeld; Anil Seetharam; Pratima Sharma; Jose Tallaj; Darshana M Dadhania; Lisa B VanWagner
Journal:  Am J Transplant       Date:  2022-03-31       Impact factor: 9.369

Review 2.  Cardiac evaluation of the kidney or liver transplant candidate.

Authors:  Paul Emile Levy; Sadiya S Khan; Lisa B VanWagner
Journal:  Curr Opin Organ Transplant       Date:  2021-02-01       Impact factor: 2.640

Review 3.  Preoperative Evaluation of Coronary Artery Disease in Liver Transplant Candidates: Many Unanswered Questions in Clinical Practice.

Authors:  Maria Bonou; Sophie Mavrogeni; Chris J Kapelios; Marina Skouloudi; Constantina Aggeli; Evangelos Cholongitas; George Papatheodoridis; John Barbetseas
Journal:  Diagnostics (Basel)       Date:  2021-01-05

4.  Preoperative high-sensitivity troponin I and B-type natriuretic peptide, alone and in combination, for risk stratification of mortality after liver transplantation.

Authors:  Young-Jin Moon; Hye-Mee Kwon; Kyeo-Woon Jung; Kyoung-Sun Kim; Won-Jung Shin; In-Gu Jun; Jun-Gol Song; Gyu-Sam Hwang
Journal:  Korean J Anesthesiol       Date:  2020-08-26

Review 5.  Cardiac Risk Assessment in Liver Transplant Candidates: Current Controversies and Future Directions.

Authors:  Pranab M Barman; Lisa B VanWagner
Journal:  Hepatology       Date:  2021-06       Impact factor: 17.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.